Clinical Trial Update: Clinical Trial of High Dose Lisdexamfetamine and Contingency Management in MA Users [Phase 2]

View source ↗

Summary

A Phase 2 study is testing high-dose lisdexamfetamine combined with contingency management for methamphetamine use disorder. The trial, sponsored by CHUM in Mon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Use Disorder

Drugs mentioned

• Lisdexamfetamine (lisdexamfetamine dimesylate)

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Methamphetamine Abuse, Methamphetamine-dependence | Phase 2 | Status: RECRUITING